Eva Kumlien Selected Research

Eva Kumlien Research Topics

Disease

9	Epilepsy (Aura) 01/2022 - 10/2003
5	Seizures (Absence Seizure) 01/2021 - 03/2010
4	COVID-19 11/2022 - 08/2020
4	Stroke (Strokes) 01/2022 - 12/2016
2	Coma (Comas) 01/2020 - 01/2015
2	Focal Cortical Dysplasia 11/2019 - 03/2009
2	Status Epilepticus (Complex Partial Status Epilepticus) 09/2013 - 05/2012
2	Gliosis 01/2012 - 10/2009
2	Temporal Lobe Epilepsy 11/2011 - 05/2007
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 11/2009 - 07/2007
1	Infarction (Infarctions) 11/2022
1	Inflammation (Inflammations) 11/2022
1	Leukocytosis (Pleocytosis) 10/2021
1	Neurologic Manifestations (Neurological Manifestations) 10/2021
1	Muscular Diseases (Myopathy) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Polyneuropathies (Polyneuropathy) 01/2021
1	Immunoglobulin G4-Related Disease 01/2021
1	Neuroinflammatory Diseases 08/2020
1	Cerebrospinal Fluid Leak 08/2020
1	Encephalitis (Encephalitis, Rasmussen) 08/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Leukoencephalopathies 02/2019
1	Atrial Fibrillation 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Drug Resistant Epilepsy 01/2018
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 01/2017
1	Rheumatic Diseases (Rheumatism) 01/2017
1	Infections 09/2014
1	Hyponatremia 09/2013
1	Hypersensitivity (Allergy) 05/2012
1	Acquired CJD 01/2012
1	Malformations of Cortical Development 03/2009
1	Tuberous Sclerosis (Bourneville's Disease) 03/2009
1	Ischemia 07/2007
1	Partial Epilepsies (Epilepsy, Partial) 05/2007
1	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2003
1	Hemorrhage 10/2003
1	Hippocampal Sclerosis 10/2002

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 10/2021 - 03/2009
5	Anticonvulsants (Antiepileptic Drugs)IBA 11/2019 - 05/2012
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2021
3	Pharmaceutical PreparationsIBA 01/2022 - 05/2007
3	Levetiracetam (Keppra)FDA LinkGeneric 11/2019 - 05/2012
3	Glucose (Dextrose)FDA LinkGeneric 02/2019 - 10/2009
3	Glutamic Acid (Glutamate)FDA Link 11/2009 - 10/2003
2	Glial Fibrillary Acidic ProteinIBA 11/2022 - 01/2012
2	Immunoglobulin G (IgG)IBA 10/2021 - 01/2021
2	AntibodiesIBA 11/2019 - 01/2012
2	Carbamazepine (Tegretol)FDA LinkGeneric 01/2019 - 05/2007
2	Glutamine (L-Glutamine)FDA Link 11/2009 - 07/2007
2	Pyruvic Acid (Pyruvate)IBA 11/2009 - 07/2007
1	C-Reactive ProteinIBA 11/2022
1	Contrast MediaIBA 11/2022
1	UbiquitinIBA 11/2022
1	HydrolasesIBA 11/2022
1	EnzymesIBA 01/2022
1	ProteomeIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	AntigensIBA 11/2019
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2019
1	SD 1029IBA 07/2017
1	Rituximab (Mabthera)FDA Link 01/2017
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 09/2013
1	Kainic Acid (Kainate)IBA 09/2013
1	BenzodiazepinesIBA 05/2012
1	Phenytoin (Dilantin)FDA LinkGeneric 05/2012
1	PrionsIBA 01/2012
1	Substance PIBA 11/2011
1	vofopitantIBA 11/2011
1	NeuropeptidesIBA 11/2011
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 11/2011
1	Cholinergic Agents (Cholinergics)IBA 03/2010
1	Antidepressive Agents (Antidepressants)IBA 03/2010
1	Antipsychotic Agents (Antipsychotics)IBA 03/2010
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2009
1	IronIBA 10/2003
1	phenyl-N-tert-butylnitroneIBA 10/2003
1	Free RadicalsIBA 10/2003
1	Amino Acids FDA Link 10/2003

Therapy/Procedure

2	Therapeutics 01/2018 - 10/2002
1	Critical Care (Surgical Intensive Care) 11/2022
1	Plasma Exchange 08/2020
1	Immunotherapy 11/2019
1	Ketogenic Diet 01/2018
1	Artificial Respiration (Mechanical Ventilation) 09/2014
1	Intraperitoneal Injections 09/2013